Study of Out of Specification for Tisagenlecleucel
Novartis
Novartis
National Cancer Institute (NCI)
Beijing Biotech
University of Washington
AstraZeneca
British Columbia Cancer Agency
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Vironexis Biotherapeutics Inc.
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Autolus Limited
Fred Hutchinson Cancer Center
Beijing GoBroad Hospital
Arkansas Children's Hospital Research Institute
Zhejiang University
Children's Oncology Group
Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Schrödinger, Inc.
University of Washington
OHSU Knight Cancer Institute
Imugene Limited
AstraZeneca
University of California, San Francisco
Grit Biotechnology
St. Jude Children's Research Hospital
Medical College of Wisconsin
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Stanford University
Institute of Hematology & Blood Diseases Hospital, China
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Medical College of Wisconsin
Great Ormond Street Hospital for Children NHS Foundation Trust
Peking University People's Hospital
Fifth Affiliated Hospital, Sun Yat-Sen University